Haemostasis Flashcards

1
Q

define haemostasis?

A

arrest of bleeding from a broken/ruptured blood vessel

  • prevents significant blood loss after vascular injury
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what does haemostasis depend on?

A
  • blood vessel wall
  • platelets + other blood cells
  • coagulation proteins/other proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

haemostasis brief process

A
  1. localised vasoconstriction - dec blood flow to injury site + stops blood loss
  2. primary haemostasis (platelet plug form) - plugs breach in blood vessel
  3. secondary haemostasis (blood clotting/coagulation) - strengthens + reinforces platelet plug
  4. tertiary haemostasis (fibrinolysis) - dissolves clot once blood vessel integrity restored
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

localised vasoconstriction

A
  • injured blood vessel constricts
  • mediated by reflex neurogenic mechanisms + released—> vasoconstrictor (e.g. endothelin)
  • transient - lasts up to 30 mins
  • briefly reduces blood loss to injury site
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what does the endothelium act as?

A

physical barrier

separates circulating platelets from thrombogenic substances in extravascular space

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

when the procoagulant sub endothelial matrix is exposed, what does it initiate?

A

PRIMARY HAEMOSTASIS

  • platelet adhesion
  • platelet activation
  • platelet aggregation
  • platelet plug formation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

platelet adhesion

A
  • on endothelial injury, platelets bind —> exposed subendothelial matrix proteins (e.g. collagen)
  • bind via transmembrane glycoprotein receptors —>

> GP1b-IX-V binds von willebrand factor
GPVI + alpha-2-beta-1 (GPIa-IIa) binds directly to collagen
GP1c/IIa binds fibronectin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

platelet activation

A

UNDERGOES CHANGES

shape change - discoid shape —> elongated cells with cytoplasmic extensions

granule release -
> alpha granules: vwf, p-selection, FV + FXIII
> dense granules: ADP, serotonin, ca2+

membrane phospholipid metabolism —> inc thromboxane A2 (TXA2) prod

activation + expression of GPIIb/IIIa receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

platelet aggregation + plug formation

A
  • agonist activated platelet GPIIb/IIIa receptors bind fibrinogen
  • —> crossbridges with platelets next to
  • —> formation of primary haemostatic plug

plug only good for haemorrhage in small blood vessels

activated + aggregated platelets form. phospholipid membrane for secondary process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what does major activation of secondary haemostasis need?

A
  • neg charged phospholipid-rich membrane surface (on activated platelets, endothelial cells..)
  • enzyme coat factor, substrate, cofactor, ca2+
  • 3 pathways: intrinsic, extrinsic + common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

clotting factors of secondary haemostasis?

A
  • serial activation of inactive plasma proteins (alpha + beta golublins) —> active enzymes + cofactors
  • activated enzyme + inactive plasma protein —> active enzyme
  • happens until fibrinogen —> fibrin by thrombin
  • all enzymes = serine proteases

most factors synthesised in liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

classification of coagulation factors

state the coag. factor and properties of the contact group

A

XII, XI prekallikrein, HMW kininogen

needs contact with negative charged surface for activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

classification of coagulation factors

state the coag. factor and properties of the prothrombin group?

A

II, VII, IX, X

needs vitamin K for synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

classification of coagulation factors

state the coag. factor and properties of the fibrinogen group?

A

I, V, VIII, XIII

large molecules absent from serum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

coagulation pathways

A
  • intrinsic —> all components occur in blood
  • extrinsic —> needs factor not in blood stream

both activate common pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

intrinsic

A

SLOW (when blood in contact with collagen in damaged blood vessel)

  • PK
  • HMW K
  • factor XII, XI, IX, VIII
  1. FXII (hageman factor) = primary complex with HMWK + PK on collagen —> activation of FXII
  2. FXIIa activates FXI -> activates -> FIX
  3. FIXa = complex with FVIIa, ca2+ + phosphatidylserine (intrinsic tenase)
  4. —> activates FX (common pathway) —> thrombin gen
17
Q

extrinsic

A

FAST (traumatic injury)
- interaction between TF, FVII and ca2+

TF (FIII, tissue thromboplastin)

  • cell bound glycoprotein
  • in extravascular tissues e.g. fibroblasts
  • exposed to blood when endothelial barrier breached
  1. contact with blood, extravascular cells release TF
  2. TF forms complex with FVII + ca2+ (extrinsic tenase)
  3. TF-FVIIa complex activates FX of common pathway —> thrombin gen)
    can activated FX on intrinsic pathway (alternative pathway)
18
Q

common

A
  • factor X , V
  • factor II ( prothrombin)
  • factor I (converts fibrinogen —> fibrin)
  1. activation of FX
  2. conversion of prothrombin (FII) to thrombin (FIIa)
  3. cleavage of fibrinogen (FI) to fibrin (FIa)
  4. polymerisation of fibrin
  5. stabilisation of fibrin polymers by FXIII
19
Q

what are the limitations of the coagulation cascade model?

A
  • doesn’t fully explain how blood clots in vivo
  • assumes intrinsic + extrinsic pathways independently capable of initiating clot form
  • deficiency of FXII, HMWK, PK doesn’t lead to bleeding tendency
  • FVIII/IX deficiency —> serious bleeding tendency. even through extrinsic pathway intact
  • FVII deficiency —> serious bleeding tendency. even though intrinsic pathway intact
20
Q

modern cell based model

A

secondary haemostasis happens in different overlapping steps

  • initiation
  • amplification
  • propagation

needs 2 cell types:

  • TF-bearing cells
  • platelets ———> kept apart until vascular injury
21
Q

modern cell based model

initiation

A
  • TF released from injured cells + monocytes
  • TF + FVIIa —> TF/FVIIa complex
  • TF/FVIIa activates small amount FIX + FX —> generates small amount thrombin
  • FXII have minor role in activation of FXI
22
Q

modern cell based model

amplification

A
  • thrombin activates FV to Va
  • FVIII —> FVIIIa + activates more platelets
  • also activates FXI to FXIa
23
Q

modern cell based model

propagation

A
  • FXa produced when TF/FVIIa complex activates FIX
  • FIXa + FVIIIa —> tenase complex
  • —> converts more FX to FXa
  • FXa + FVa + ca + phoshoplipid (PL) surface (activated platelets) form prothrombinase complex
  • turns prothrombin —> thrombin (large amounts)
24
Q

tertiary haemostasis

A

fibrinolysis

  • ensures localisation of fibrin clot formation + clot removal
  • carried out by plasmin (proteolytic enzyme)
  • degrades fibrin mesh
  1. release of plasminogen activators (t-PA, FXIIIa, v-PA, kallikrein)
  2. plasmin produced from inactive precursor, plasminogen
  3. clot lysis + release of degradation products
25
Q

regulation of haemostasis

A
  • primary + secondary haemostasis restricted to local site of vascular injury
  • size of primary + secondary plugs restricted —> keep blood vessels patent
  • fibrinolytic system regulated —> ensure removal of unwanted fibrin clots + preservation of fibrin
  • regulation achieved via ENDOGENOUS antithrombotic + antifibrinolytic systems
26
Q

endothelium mechanism of action

A

global haemostasis: physical barrier

primary haemostasis: secrete platelet antagonists (nitric oxide, ADPase, prostacyclin)

secondary haemostasis: expresses thromobmodulin
- binds thrombin + activates protein C (inhibits co-factors FVa, FVIIa) + endothelial protein c receptor
- expresses surface heparin-like (glycosaminoglycans)
—> enhances AT and TFPI activity

fibrinolysis: secrete fibrinolytic inhibit e.g. plasminogen activation inhibitor - 1 and 2

27
Q

plasma proteins (protease inhibitors) mechanism of action

A

global haemostasis: produced in liver

e.g. alpha2 - macroglobulin
alpha1 - antitrypsin

acts as non-specific inhibition of serum proteases

28
Q

regulators of secondary haemostasis

tissue factor pathway inhibitor

A
  • made in endothelial cells
  • inhibits TF-FVIIa + TF-FVIIa-FXa complex
  • inhibits free factor Xa generation by TF-FVIIa complex (initiation of secondary haemostasis)
29
Q

regulators of secondary haemostasis

antithrombin III (AT III)

A
  • made in liver
  • inhibits FIIa, FXa, FXIIa, FIXa, FXIa, TF-FVIIa
  • activity enhanced by heparin (exogenous) + heparin-like GAGs on endothelial cells
30
Q

regulators of secondary haemostasis

protein c

A
  • vitamin k dependent
  • made in liver
  • plasma glycoprotein
  • inactivates FVa, FVIIa
  • activated by thrombin via binding to thrombomodulin on endo. cells
  • further activated by binding of thrombomodulin-thrombin complex to endothelial protein c receptor
31
Q

regulators of secondary haemostasis

protein s

A
  • vitamin k dependent
  • made in liver
  • cofactor for TFPI + activated protein c
  • exists as free/bound to acute phase protein - C4 finding protein

ONLY FREE PROTEIN S

32
Q

regulators of fibrinolysis

thrombin activatable fibrinolytic inhibitor (TAFI)

A
  • carboxypeptidase B
  • made in liver
  • binds to lysine residues in fibrin —> prevents plasminogen binding + activation
  • activated by thrombin burst (amp + prop of 2 haem)
33
Q

regulators of fibrinolysis

plasminogen activator inhibitor 1 (PAI-1)

A
  • made by endothelial cells
  • binds + inactivates tissue plasminogen activator
  • inhibited by thrombin-thrombomodulin complex
34
Q

regulators of fibrinolysis

alpha2- antiplasmin

A
  • binds + inactivates plasmin

- made in liver

35
Q

regulators of fibrinolysis

polyphosphates

A
  • released from dense granules in platelets during activation
  • forms dense fibrin network —> resists lysis
36
Q

regulators of fibrinolysis

extracellular nuclear material (histones, DNA…)

A
  • binds to fibrin network
  • inhibits fibrin degradation
  • promotes PAI-1 inhibition of tPA